Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999
Clinical Infectious Diseases, Volume 31, No. 6, Year 2000
Notification
URL copied to clipboard!
Description
The objective of this study was to estimate the prevalence of and risk factors for clinical lipodystrophy (LD) and metabolic disorders in human immunodeficiency virus (HIV) type 1-infected patients. A cross-sectional survey of the Aquitaine Cohort was performed in January 1999. The clinical diagnosis of LD was categorized as fat wasting (FW), peripheral fat accumulation (FA), and mixed syndromes (MS). Of the 581 patients studied, 61% were treated with protease inhibitors. The overall prevalence of LD was 38% (95% confidence interval [CI], 32-42): prevalence of FW was 16% (95% CI, 13-18); of FA, 12% (95% CI, 10-15); and of MS, 10% (95% CI, 8-13). The prevalences of metabolic abnormalities were 49% (95% CI, 44-53) for lipid disorders and 20% (95% CI, 17-23), for glucose disorders. Factors associated with LD were age (for FW and MS), male sex (for FW), AIDS stage (for MS), body mass index (for FW and FA), waist-to-hip ratio (for FA and MS), and duration of antiretroviral treatment (for FW). © 2000 by the Infectious Diseases Society of America. All rights reserved.
Authors & Co-Authors
Thíébaut, Rodolphe
France, Paris
Inserm
Ékouévi, Didier Koumavi
France, Talence
Centre Hospitalier Universitaire de Bordeaux
Malvy, Denis Jean Marie
France, Talence
Centre Hospitalier Universitaire de Bordeaux
Morlat, Philippe
France, Talence
Centre Hospitalier Universitaire de Bordeaux
Farbos, Sophie
Unknown Affiliation
Marimoutou, Catherine
France, Talence
Centre Hospitalier Universitaire de Bordeaux
Dabis, Franćois Ç.Ois
France, Paris
Inserm
France, Bordeaux
Université de Bordeaux
Statistics
Citations: 160
Authors: 7
Affiliations: 3
Identifiers
Doi:
10.1086/317477
ISSN:
10584838
Research Areas
Infectious Diseases
Noncommunicable Diseases
Study Design
Cross Sectional Study
Cohort Study
Study Approach
Quantitative
Participants Gender
Male